Berg

has been named a in Frost & Sullivan’s first-ever Frost Radar in report in the Pharmaceutical Industry. BERG was selected from 50 global companies for its unique use of AI and biology as well as the strength of our partnerships.

BERG Named Visionary in Frost & Sullivan's First-Ever Frost Radar™ AI in Drug Discovery Report in the Pharmaceutical Industry /PRNewswire/ -- BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, has been...

Last Thursday, BERG CEO Niven Narain was a guest of where he discussed the intersection of AI and biology as a viable solution in enhancing drug discovery and development to help save patient lives. You can watch his interview on the Episode 330 recap:

Digital Trends Live: SXSW Shrinks, Twitter "Fleets" | Digital Trends On this Digital Trends Live, we discuss trending tech stories including Netflix and Apple backing out of SXSW, Twitter’s “Fleets,” and Stadia finally goes 4K.

BERG's CEO, Niven R. Narain, recently spoke to Robert Reiss, Founder and CEO, The CEO Forum Group where he discussed BERG’s initiatives with AI, Biology and our approach to efficiently advancing therapeutics into human trials. The summary of Dr. Narain’s discussion with Mr. Reiss is featured on Forbes.com titled “Transforming Drug Discovery Through Artificial Intelligence”. The article highlights BERG’s focus on a patient-first approach to drug development, using AI to merge biology and technology to map human disease.

The article describes the AI-powered development efforts of BPM 31510 in oncology, specifically in aggressive cancers that was informed by leveraging comprehensive multi-omic capture of patient biology. BERG’s platform is disease agnostic and is focused on understanding the biological basis of disease with a goal to transform the future of healthcare by creating more precision and predictability in the process of advancing drugs to the market.

https://www.forbes.com/sites/robertreiss/2020/03/03/transforming-drug-discovery-through-artificial-intelligence/

Transforming Drug Discovery Through Artificial Intelligence Often acknowledged as a game-changing technology, AI offers untapped potential in improving established ways of doing business, as well as with new opportunities in meeting and addressing critical pain points across many industries, including banking, manufacturing and healthcare.